Recent advances in closed-loop insulin delivery.

Adolescent Adult Age of Onset Aged Aged, 80 and over Blood Glucose / analysis Child Child, Preschool Diabetes Mellitus, Type 1 / blood Female Humans Insulin / administration & dosage Insulin Infusion Systems / trends Middle Aged Pancreas, Artificial / trends Pregnancy Young Adult
Artificial pancreas Closed loop insulin delivery Diabetes technology Type 1 diabetes

Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
02 2022
Historique:
received: 01 08 2021
revised: 05 11 2021
accepted: 24 11 2021
pubmed: 11 12 2021
medline: 23 2 2022
entrez: 10 12 2021
Statut: ppublish

Résumé

Since the discovery of insulin 100 years ago, we have seen considerable advances across diabetes therapies. The more recent advent of glucose-responsive automated insulin delivery has started to revolutionise the management of type 1 diabetes in children and adults. Evolution of closed-loop insulin delivery from research to clinical practice has been rapid, and multiple systems are now commercially available. In this review, we summarise key evidence on currently available closed-loop systems and those in development. We comment on dual-hormone and do-it-yourself systems, as well as reviewing clinical evidence in special populations such as very young children, older adults and in pregnancy. We identify future directions for research and barriers to closed-loop adoption, including how these might be addressed to ensure equitable access to this novel therapy.

Identifiants

DOI: 10.1016/j.metabol.2021.154953 PMID: 34890648 PMC: PMC8792215
pubmed: 34890648
pii: S0026-0495(21)00253-5
doi: 10.1016/j.metabol.2021.154953
pmc: PMC8792215
mid: NIHMS1765036
pii:
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154953

Subventions

Organisme : NIDDK NIH HHS
ID : UC4 DK108520
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest RH reports having received speaker honoraria from Eli Lilly and Novo Nordisk, serving on advisory panel for Eli Lilly and Novo Nordisk; receiving personal fees from BBraun and Abbott Diabetes Care; patents related to closed-loop insulin delivery, shareholder and director at CamDiab. JW has no conflicts of interest to declare.

Références

Diabetes Technol Ther. 2021 Sep;23(9):601-608
pubmed: 33784196
J Diabetes Sci Technol. 2017 Nov;11(6):1080-1088
pubmed: 28367636
Diabetes Care. 2020 Oct;43(10):2537-2543
pubmed: 32723843
J Diabetes Sci Technol. 2020 Sep;14(5):868-877
pubmed: 31847570
Diabetes Technol Ther. 2022 Feb;24(2):113-119
pubmed: 34524003
Chronic Illn. 2022 Dec;18(4):742-756
pubmed: 33472409
Diabetes Care. 2021 Jul;44(7):1630-1640
pubmed: 34099518
Diabetes Care. 2018 Aug;41(8):1572-1578
pubmed: 29936422
Diabetes Care. 2016 Nov;39(11):2019-2025
pubmed: 27612500
Diabetologia. 2021 May;64(5):1007-1015
pubmed: 33550442
Diabetes Care. 2020 Mar;43(3):e40-e42
pubmed: 31969340
N Engl J Med. 2019 Oct 31;381(18):1707-1717
pubmed: 31618560
Diabetes Technol Ther. 2021 May;23(5):367-375
pubmed: 33226840
Diabetes Technol Ther. 2020 Jun;22(6):468-475
pubmed: 32048877
Lancet Diabetes Endocrinol. 2020 Apr;8(4):313-324
pubmed: 32135138
Diabetes Care. 2020 Dec;43(12):3024-3033
pubmed: 33055139
Diabetes Care. 2017 Jun;40(6):764-770
pubmed: 28351897
Diabetes Care. 2019 Apr;42(4):594-600
pubmed: 30692242
Diabetes Care. 2021 Apr;44(4):969-975
pubmed: 33579715
Diabetes Technol Ther. 2019 Jan;21(1):11-19
pubmed: 30585770
Diabetes Obes Metab. 2021 Jun;23(6):1389-1396
pubmed: 33606901
BMJ. 2006 Jul 22;333(7560):177
pubmed: 16782722
PLoS One. 2019 Mar 8;14(3):e0212013
pubmed: 30849076
Diabetes Care. 2020 Nov;43(11):2721-2729
pubmed: 32907828
Diabetes Care. 2019 Dec;42(12):2190-2196
pubmed: 31548247
Diabet Med. 2019 Mar;36(3):279-286
pubmed: 30183096
N Engl J Med. 2020 Aug 27;383(9):836-845
pubmed: 32846062
Lancet. 2017 Jan 28;389(10067):369-380
pubmed: 28007348
J Diabetes Sci Technol. 2021 Nov;15(6):1243-1251
pubmed: 34315267
Diabetes Technol Ther. 2021 May;23(5):384-391
pubmed: 33226837
Diabetes Technol Ther. 2019 Mar;21(3):119-127
pubmed: 30720338
Diabetes Technol Ther. 2013 Aug;15(8):628-33
pubmed: 23829285
Diabetologia. 2021 Sep;64(Suppl 1):1-380
pubmed: 34468792
Front Endocrinol (Lausanne). 2019 Jan 18;9:818
pubmed: 30713524
Diabetes Care. 2020 Feb;43(2):480-483
pubmed: 31796571
Diabetologia. 2017 Sep;60(9):1668-1677
pubmed: 28597075
Lancet Diabetes Endocrinol. 2017 Apr;5(4):261-270
pubmed: 28094136
BMJ. 2018 Apr 18;361:k1310
pubmed: 29669716
Pediatr Diabetes. 2019 Sep;20(6):794-799
pubmed: 31140654
Diabetes Care. 2020 Mar;43(3):597-606
pubmed: 31974099
Lancet. 2021 Jan 16;397(10270):208-219
pubmed: 33453783
Lancet. 2018 Oct 13;392(10155):1321-1329
pubmed: 30292578
JAMA Pediatr. 2021 Dec 1;175(12):1227-1235
pubmed: 34633418
Endocr Rev. 2019 Dec 1;40(6):1521-1546
pubmed: 31276160
Diabet Med. 2019 Mar;36(3):269-278
pubmed: 30098219
N Engl J Med. 2013 Jul 18;369(3):224-32
pubmed: 23789889
J Diabetes Metab Disord. 2020 May 30;19(2):1615-1629
pubmed: 32837953
Diabetes Care. 2008 May;31(5):934-9
pubmed: 18252903
Diabetes Care. 2018 Jul;41(7):1391-1399
pubmed: 29535135
J Diabetes Sci Technol. 2018 Nov;12(6):1125-1131
pubmed: 30288999
Diabetes Care. 2018 Oct;41(10):2155-2161
pubmed: 30089663
Diabetes Care. 2021 Jun;44(6):e118-e120
pubmed: 33906916
Diabetes Care. 2018 Dec;41(12):2634-2636
pubmed: 30305346
Diabetes Care. 2018 Dec;41(12):2552-2559
pubmed: 30352894
Diabetes Obes Metab. 2021 Mar;23(3):655-660
pubmed: 33269551
Diabetes Technol Ther. 2021 Jul;23(7):482-490
pubmed: 33555982
Diabetes Technol Ther. 2019 Aug;21(8):462-469
pubmed: 31140878
Pediatr Diabetes. 2020 Mar;21(2):310-318
pubmed: 31837064
BMJ. 2011 Apr 13;342:d1855
pubmed: 21493665
Diabetes Care. 2016 Jul;39(7):1143-50
pubmed: 27208316
Diabetologia. 2015 Apr;58(4):687-90
pubmed: 25537835
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Care. 2020 Jan;43(1):29-36
pubmed: 31575640
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Diabetes Care. 2020 Sep;43(9):2146-2152
pubmed: 32661108
Diabet Med. 2018 Apr;35(4):450-459
pubmed: 29337384
Curr Diabetes Rev. 2020;16(4):313-326
pubmed: 31203802
JAMA. 2020 Jun 16;323(23):2397-2406
pubmed: 32543682
Diabetes Obes Metab. 2021 Apr;23(4):961-970
pubmed: 33336850
Front Pediatr. 2021 Apr 30;9:679484
pubmed: 33996702
Lancet Digit Health. 2019 May;1(1):e17-e25
pubmed: 33323237
Diabetes Technol Ther. 2017 Sep;19(9):527-532
pubmed: 28767276
Diabetes Care. 2021 Mar;44(3):844-846
pubmed: 33431420
Diabetes Care. 2019 Jul;42(7):1344-1347
pubmed: 31221700
Can J Diabetes. 2021 Dec;45(8):734-742
pubmed: 33888413
Diabetologia. 2021 May;64(5):1059-1065
pubmed: 33550440

Auteurs

Julia Ware (J)

Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.

Roman Hovorka (R)

Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom. Electronic address: rh347@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Facteurs âges › Âge de début › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Glycémie › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Diabète de type 1 › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones pancréatiques › Insulines › Insuline › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Équipement et fournitures › Équipement chirurgical › Organes artificiels › Pompes à perfusion › Pompes à insuline › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Équipement et fournitures › Équipement chirurgical › Organes artificiels › Pancréas artificiel › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Recent advances in closed-loop insulin delivery.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Recent advances in closed-loop insulin delivery.